---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-25-000015"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:10:21.011085+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# PacBio appoints NeoGenomics CEO Chris Smith to board; David Meline resigns

## Summary
- Chris Smith, CEO of NeoGenomics (NEO), appointed to PacBio Board effective Jan 30, 2025.
- David Meline resigned from Board effective Jan 30, 2025; no disagreement cited.
- Smith brings diagnostics and genomics expertise as PacBio expands into clinical genomics.
- Smith previously led Ortho Clinical Diagnostics (sold to Quidel) and Cochlear Limited.

## SEC filing metadata
- accession: 0001299130-25-000015
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/pacb-20250124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-25-000015
- JSON: https://secwatch.observer/filing/0001299130-25-000015.json
- Plain text: https://secwatch.observer/filing/0001299130-25-000015.txt

## Key facts
- Executive change
  Christopher M. Smith was appointed as Class III Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
  - Action: appointed
  - Role: Class III Director
  source text: appointed Christopher M. Smith to serve as a Class III director effective January 30, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm
- Executive change
  David Meline resigned as Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
  - Action: resigned
  - Role: Director
  source text: David Meline, a member of the Board, notified the Company of his resignation from the Board, effective January 30, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913025000015/0001299130-25-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.